Skip to main content
Premium Trial:

Request an Annual Quote

Gerald Möller

Gerald Möller has informed Illumina that he will retire from its board of directors, effective immediately before the firm's 2015 annual meeting of stockholders. He has been a director at Illumina since July 2010 and is currently an advisor at HBM Bio Ventures, a Swiss investment firm focusing on biotechnology, emerging pharma, and medical technology. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.